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Articles
Repair and regeneration are universal phenomenain the biological world, but the capacity for regenera-
tion varies considerably among species. Some invertebrates,
such as earthworms, readily regenerate two new and genetically
identical individuals when they are cut in half. Amphibians
such as newts can regenerate whole limbs, retinas, eye lenses,
spinal cords, and tails, as well as upper and lower jaws. Both
invertebrates and amphibians replace lost or damaged organs
and tissues with new ones that are identical in structure or
function to the original, in a process called complete regen-
eration. For mammals, the situation is apparently different.
In most instances, mammals are capable only of incomplete
regeneration: Although the function of the organ may be
recovered, the structure will not be restored after part of the
tissue has been damaged within a specific organ.
Two cellular mechanisms are involved in endogenous 
regeneration: morphallaxis, or renewal of lost tissue, and
epimorphosis, or regeneration of a piece of an organism by
way of cell proliferation on the cut surface. Both necessitate
the participation of stem cells or other progenitor cells.
During morphallaxis, the remaining undifferentiated cells
simply migrate to the site and differentiate into the special-
ized cells, with little cellular proliferation. Epimorphosis,
however, requires preexisting stem cells or dedifferentiation-
generated progenitor cells to proliferate, differentiate, and
finally replace the lost cells. The process by which the hydro-
zoan cnidarian Hydra regenerates a severed tentacle illus-
trates morphallaxis. The urodele amphibians, in contrast,
uniquely use a cellular dedifferentiation mechanism to re-
generate a variety of tissues.
For mammals, epimorphic regeneration is largely limited
by an irreversible differentiation process, although it has
been demonstrated that stem cells are activated during the 
regeneration of muscles, bones, epithelia, and some other 
tissues (Ding and Schultz 2004). Because it is difficult for
mammals, especially humans, to repair and regenerate dam-
aged and diseased tissues, organ transplantation has been
developed in recent years to replace damaged or diseased
organs. But the limited number of donors of compatible or-
gans and the host-versus-graft reaction are still hurdles that
prevent the widespread use of this therapeutic measure.
Therefore, three strategies have been put forward to improve
the regenerative capacity of mammals: stem cell transplan-
tation, cell-seeded scaffold embedding (tissue engineering
technology), and local induction of dedifferentiation in 
mature cells (Odelberg 2002).
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Dedifferentiation: A New
Approach in Stem Cell Research
SA CAI, XIAOBING FU, AND ZHIYONG SHENG
Dedifferentiation is an important biological phenomenon whereby cells regress from a specialized function to a simpler state reminiscent of stem
cells. Stem cells are self-renewing cells capable of giving rise to differentiated cells when supplied with the appropriate factors. Stem cells that are
derived by dedifferentiation of one’s own cells could be a new resource for regenerative medicine, one that poses no risk of genetic incompatibility or
immune rejection and provokes fewer ethical debates than the use of stem cells derived from embryonic tissue. Until now, it has not been quite clear
why some differentiated cell types can dedifferentiate and proliferate, whereas others cannot. A better understanding of the mechanisms involved in
dedifferentiation may enable scientists to control and possibly alter the plasticity of the differentiated state, which may lead to benefits not only in
stem cell research but also in regenerative medicine and even tumor biology. If so, dedifferentiation will offer an ethically acceptable alternative route
to obtain an abundant source of stem cells. Dedifferentiation is likely to become a new focus of stem cell research. Here we compile recent advances
in this emerging but significant research, highlighting its central concepts, research findings, possible signaling pathways, and potential applications.
Keywords: cells, stem cells, dedifferentiation, regeneration, signaling pathways
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Stem cells are self-renewing, nondifferentiated cells with the
ability to differentiate into a number of specialized phenotypes
in response to appropriate signals (Körbling and Estrov
2003). They are found in embryonic and adult tissues, and thus
are traditionally classified as embryonic stem cells and adult
stem cells, also known as tissue-specific stem cells. Because of
their great potential for differentiation, stem cells have attracted
much attention as a therapeutic measure for the treatment of
several conditions, including cardiovascular diseases, neuro-
degenerative diseases, musculoskeletal diseases, diabetes, and
aging. There are still many obstacles to overcome, however,
before stem cells can be used in cell replacement therapy.
Among them are a lack of stable and efficient techniques to
induce a specified differentiation, the limited sources for
stem cells, immune rejection, and ethical issues, to name a few.
It is imperative to find a clinically useful and ethically 
acceptable way to obtain stem cells.
Most of the problems associated with stem cells could be
averted if the process of dedifferentiation could be induced.
Obtaining cells able to multiply and develop into a specific 
tissue would have advantages over cell transplantation and 
cell-seeded scaffolds (Odelberg 2002). First, the employment
of endogenous cells during this process should preclude im-
mune rejection. Second, the remaining cells of the damaged
tissues, or the surviving cells adjacent to the injury, may un-
dergo dedifferentiation; these dedifferentiated cells may have
been primed to redifferentiate into the appropriate cell types,
as occurs during regeneration in newts (Davenport 2005).
Third, the use of the cells of patients themselves instead of
embryonic stem cells to regenerate damaged tissues is less 
likely to provoke ethical disputes. Thus, dedifferentiation
might be an ethically acceptable route for reaping an abun-
dant source of stem cells, without the risk of genetic in-
compatibility and tissue rejection. In this overview, we compile
recent advances in the research on dedifferentiation of
mature lineage-committed cells into stem cells or progenitor
cells, highlighting the important biological phenomena and
their possible mechanisms.
What is dedifferentiation?
A single multicellular organism consists of a variety of different
cell types. All of these cells are derived from a zygote through
serial processes of division and differentiation. During the early
development of an organism, a certain cell type divides, and
then its descendants gradually form stable differences in
morphology, structure, and function, finally producing nu-
merous different cell phenotypes. This process, differentiation,
is the fundamental basis for development. During animal
development, cells become progressively constrained to a
certain cell type, and the capacity to respond to a variety of
differentiation signals declines after each generation. In other
words, the process of differentiation gradually reduces the 
potential of a cell. In the final stage of differentiation, the cell
is thought to stop dividing permanently.
There is now much evidence demonstrating the remark-
able ability of some differentiated cells to convert into a 
completely different phenotype. The conversion of one 
cellular phenotype to another is referred to as transdifferen-
tiation (Li et al. 2005). The most commonly accepted exam-
ples of transdifferentiation are limb regeneration in amphibia,
and the conversion of pigment epithelia into lens and neural
retinal cells (Eisenberg and Eisenberg 2003). In fact, the trans-
differentiation process undergoes two phases in succession.
In the first phase, the differentiated cells revert to cells with
an apparent stem cell or progenitor cell phenotype. In the sec-
ond phase, these dedifferentiated cells redifferentiate into
the new, differentiated cell phenotypes. Other instances of
transdifferentiation include the conversion of pancreatic cells
to hepatocytes (Shen et al. 2003) and of vascular endothelium
to smooth muscle (Frid et al. 2002). All of these experimen-
tal findings point to a dedifferentiation–redifferentiation
model rather than to direct transdifferentiation.
Dedifferentiation is a process by which cells develop in re-
verse, from a more differentiated to a less differentiated state.
The phenomenon can be observed at the levels of gene, pro-
tein, morphology, and function. At the genetic level, the cell
undergoes reversion from a differentiated cell gene expression
profile to a progenitor cell gene expression profile. During the
dedifferentiation process, development-related gene activity
is repressed, and genes that keep the cell in the undifferenti-
ated state are activated. Dedifferentiation can also be ob-
served at the protein level, as evidenced by the up-regulation
of progenitor cell–related proteins and the down-regulation
of differentiated cell–related proteins. During dedifferentia-
tion, cells also experience morphological changes: Compared
with mature cells, dedifferentiated cells are smaller, have
fewer organelles, and have a higher karyoplasmic ratio. Finally,
at the functional level, the cell regains the capacity to prolif-
erate, which means that a postmitotic cell can reenter the cell
cycle. Meanwhile, mature cells or lineage-committed cells
might become multipotent or pluripotent progenitor cells with
the potential of differentiating into a variety of cell types.
Changes at all four levels occur during dedifferentiation.
Although many researchers have declared that they have 
observed the phenomenon of dedifferentiation, their findings
were based on just one or two of the manifestations listed
above. A definitive, well-accepted criterion for dedifferenti-
ation has yet to be established. However, in the quest to un-
derstand the dedifferentiation process in a variety of cell
types and species, researchers are identifying elements that may
turn out to be common to the process and may, in the future,
serve as a definitive marker for dedifferentiation.
Dedifferentiation in animal lives
Dedifferentiation can be observed in different tissues and
organs of plants (Krikorian et al. 1981, Zhao et al. 2001, Grafi
2004), invertebrates, amphibians, and animals, including 
humans (table 1).
Dedifferentiation in amphibians. As stated earlier, some am-
phibians have the ability to regrow damaged organs and lost
body parts, such as a limb or tail (Davenport 2005). It has been
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confirmed that this process involves the phenotypic reversion
of fully differentiated cells, proceeding through dedifferenti-
ation, proliferation, and redifferentiation to form the re-
quired tissue or organ. After limb amputation in the newt, for
example, epithelial cells begin to migrate and gradually form
a mature apical epithelium cap (AEC; McGann et al. 2001).
The internal stump cells underlying the AEC lose their tissue
characteristics and dedifferentiate in response to undefined
signals. The dedifferentiated cells proliferate for a short time
to form the blastema—a mass of progenitor or pluripotent
cells—and then redifferentiate to build a replica of the lost part
of the limb. In addition, after tail amputation, the ependymal
tube, which resembles a developing neural tube, expresses
neural stem cell markers that are undetectable in a normal
urodele spinal cord. This up-regulation of neural stem cell
markers suggests the occurrence of a dedifferentiation process
in the spinal cord in response to injury (Walder et al. 2003).
The same process is also found in the regeneration of the sala-
mander jaw (Ghosh et al. 1994). During regeneration of the
newt retina or lens after its removal, the pigment epithelial cells
of the retina or dorsal iris, respectively, lose their character-
istic pigmentation and dedifferentiate to form nonpigmented
precursor cells, which in turn redifferentiate to rebuild the lost
tissues (Kodama and Eguchi 1995, Ito et al. 1999).
Dedifferentiation in mammals. A growing number of studies
indicate that when exposed to appropriate signals, certain
mammalian cell types can be induced to dedifferentiate to
progenitor cells and generate different types of functional cells
for the repair of damaged tissues.
Dedifferentiation in myoblasts. Adult skeletal myoblasts
are lineage-committed cells that either are self-renewing or
differentiate into multinucleated myotubes (Jankowski et al.
2002, Tamaki et al. 2003). Myoblast fate is mainly depen-
dent on muscle differentiation proteins known as myogenic
regulatory factors. Serum stimulation was previously found
to induce newt myotubes, but not their mammalian counter-
parts, to reenter the cell cycle.
In a study by Velloso and colleagues (2001), researchers grew
newt myoblasts and mouse myoblasts together, and induced
them to differentiate to form myotubes. During the process,
some of the differentiating mouse cells fused with differen-
tiating newt cells to become hybrid myotubes. This culture
mixture containing hybrid cells was then stimulated by serum.
After induction, the newt nuclei began to synthesize DNA as
expected. Simultaneously, some of the mouse nuclei also ini-
tiated DNA synthesis, which indicated that newt myotubes
produced some factor that made the mouse myotube nuclei
competent to respond to serum. When mouse myotubes
were treated with an extract derived from the regenerating
limbs of newts, the myotubes would dedifferentiate, as 
evidenced by their ability to reenter the cell cycle, exhibit a 
reduction in muscle differentiation proteins, and cleave to form
smaller myotubes or mononucleated cells (McGann et al.
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Table 1. Representative examples of dedifferentiation in various organisms.
Example of Signaling 
Taxon Cell type dedifferentiation Stimuli Phenomena mechanisms
Plant Mesophyll Cells of tobacco leaves Removal of Pluripotency, reentry into S phase, Two phases of chromatin 
cell wall capacity for redifferentiation decondensation
Amphibian Various Regeneration of newt Amputation, removal, Loss of the characteristics of origin, NA
limb, jaw, tail, retina, injury production of blastema, expression
lens, and spinal cord of stem cell markers, redifferentiation 
to reconstitute lost organs
Mammal Myoblast C2C12 mouse cells, Extracellular signals Down-regulation of MRFs, reentry p44/p42 MAPK
adult human myoblasts (serum, limb regeneration into cell cycle, formation of 
extract, reversine, CNTF) mononucleated cells, presentation 
of new phenotypes
Mammal Neuron Schwann cells, Injury, extracellular Acquisition of pluripotency, ERK MAPK
oligodendrocyte signals expression of neural stem cells,
precursor cells redifferentiation to different cell types
Mammal Renal RPTC Ischemia/reperfusion Undergoing EMT, expression p38 MAPK
oxidant injury of mesenchymal cell marker,
acquisition of dedifferentiated 
phenotype (elongated morphology)
Mammal Epithelial Corneal and skin Recombination of Acquisition of limbal basal Wnts, BMP/Noggin
epithelium epithelium and dermis cell phenotype, loss of the 
(corneal epithelium), expression of corneal-specific 
healing wound (skin keratin, redifferentiation to form 
epithelium) hair follicle and epidermis,
appearance of stem cell–like 
islands in the suprabasal layer,
expression of stem cell markers
Mammal Germ Sertoli cells Heat treatment Acquisition of undifferentiated ERK MAPK
phenotype, expression of ck18,
cessation of spermatogenic activity
BMP, bone morphogenetic protein; CNTF, ciliary neurotrophic factor; EMT, epithelial–mesenchymal transition; ERK, extracellular signal-regulated
kinase; MAPK, mitogen-activated protein kinase; MRF, myogenic regulatory factor; NA, not applicable; RPTC, renal proximal tubule cell.
2001). Subjecting the extract to a variety of chemical or phys-
ical treatments, such as lipid removal, freeze–thaw cycling,
boiling, and trypsin digestion, indicated that the dedifferen-
tiation signal within the extract is a protein.
Using myotubes derived from the C2C12 mouse cell line,
Odelberg and colleagues (2000) found that as yet unidenti-
fied serum factors could reduce nuclear muscle proteins to un-
detectable levels, and that most of the myotubes cleaved to
produce either smaller multinucleated myotubes or prolif-
erating mononucleated cells. Furthermore, the myotube-
derived multipotent cells could be induced to redifferentiate
into cells expressing chondrogenic, adopogenic, myogenic, and
osteogenic markers. These data suggest that mammalian
myotubes can dedifferentiate when stimulated with appro-
priate factors, as evidenced by reentry into the cell cycle,
reduction of differentiation proteins, morphological change,
or acquisition of multipotency.
The identification of small molecules that induce de-
differentiation of somatic cells would help to elucidate the 
molecular mechanism of this process and may finally allow
researchers to regenerate tissues in vivo (Chen et al. 2004). It
was previously considered a breakthrough in the study of de-
differentiation when it was demonstrated that treatment of
mouse myotubes with the microtubule-binding purine known
as myoseverin would induce the myotubes to cleave to form
mononucleated cells, which could proliferate and re-
differentiate into myotubes (Rosania et al. 2000, Duckman-
ton et al. 2005). But other researchers held different opinions
about this conclusion. They suspected that the effect of myo-
severin was most likely the result of cytoskeleton remodeling,
not true dedifferentiation. They also believed that the bona
fide dedifferentiation-inducing molecule should allow the
lineage-reversed myoblasts to regain multipotency and to
acquire the ability to differentiate into multiple cell lineages
under appropriate induction conditions. On this premise,
Chen and colleagues (2004) performed experiments that
employed a different approach. They treated C2C12 cells
with a library of 50,000 discrete small molecules to induce de-
differentiation, and then transferred these cells either to a
medium containing osteogenesis-inducing substances or to
a medium containing adipogenesis-inducing substances. In
the end, they discovered a 2,6-disubstituted purine that could
induce myogenic lineage-committed cells to become multi-
potent cells with the capacity to proliferate and redifferenti-
ate into bone and fat cells. They named the molecule
“reversine” because of its ability to reverse terminally differ-
entiated cells to progenitor cells, which in turn were able to
redifferentiate into different cell types.
Besides the many investigations conducted on rodent 
myoblasts, researchers have now conducted studies on the de-
differentiation of human skeletal myoblasts. Ciliary neuro-
trophic factor (CNTF) was previously found to play an
important role in regulating many processes within the 
nervous system. Recent studies indicate that the CNTF re-
ceptor can be highly expressed in skeletal muscle. Chen and
colleagues (2005) investigated the direct effect of CNTF on
skeletal myoblasts of the adult human and, surprisingly,
found that CNTF induced the myogenic lineage-committed
myoblasts to dedifferentiate into multipotent progenitor cells.
These dedifferentiated cells not only could proliferate for
more than 20 passages without the expression of myogenic-
specific factors but also could differentiate into new pheno-
types, mainly neurons, glial cells, smooth muscle cells, and
adipocytes. These findings are of extraordinary importance
for regeneration research, suggesting that these molecules
might be used for therapeutic applications in the future. Fur-
thermore, the formation of multipotent progenitor cells from
differentiated cells can provide helpful information to eluci-
date the molecular mechanism of dedifferentiation in the
process of regeneration.
Dedifferentiation in neurons. Many cell types that are
produced continuously, such as some epithelial cells and
hematopoietic cells, come from a slowly dividing popula-
tion of stem cells, which give rise to rapidly dividing precursor
cells and then undergo terminal differentiation. Other cell
types, however, such as Schwann cells, tend to divide infre-
quently. Following specific challenges, such as injury, Schwann
cells undergo a different process to produce new cells, perhaps
involving dedifferentiation.
Schwann cells belong to a regenerative cell type. Following
nerve injury, a differentiated, myelinating Schwann cell can
dedifferentiate, regain the potential to proliferate, and then re-
differentiate during the repair process. Harrisingh and col-
leagues (2004) found that sustained activation of Ras/Raf/ERK
(extracellular signal-regulated kinase) signaling triggered the
dedifferentiation of Schwann cells, which was indicated by
switching off the characteristic proteins of differentiated
Schwann cells (e.g., peripheral myelin protein 22 and myelin
basic protein) and reducing the levels of transcriptional 
factors that regulate the expression of Schwann cell genes.
Kondo and Raff (2000) also showed that certain extracellu-
lar signals could induce oligodendrocyte precursor cells to re-
vert to multipotential neural stem cells, which could self-renew
and give rise to neurons and astrocytes, as well as to
oligodendrocytes. These findings have important implications
for the understanding of the nerve regenerative process.
Dedifferentiation in renal cells. In contrast to the heart or
brain, the kidney can completely recover from an ischemic or
toxic insult resulting in cell death. When the kidney recovers
from ischemia or reperfusion injury, it relies on a sequence
of events that include epithelial cell spreading, and possibly
migration, to cover the exposed areas of the basement mem-
brane, followed by cell dedifferentiation, proliferation, and re-
differentiation (Thadhani et al. 1996). Following injury, cells
in the mature kidney begin to dedifferentiate, as evidenced by
the production of vimentin, a protein that is typically expressed
in the mesenchymal cells that give rise to the kidney cells
(Witzgall et al. 1994). Likewise, the neural cell adhesion mole-
cule, which is expressed in metanephric mesenchyme but
not in mature kidneys, is abundantly expressed in kidney
cells after injury (Abbate et al. 1999). After exposure to hy-
drogen peroxide stimulation, the surviving kidney cells 
Articles
658 BioScience  • September 2007 / Vol. 57 No. 8 www.biosciencemag.org
acquired a dedifferentiated phenotype (i.e., elongated in
morphology with expression of vimentin), and the epidermal
growth factor (EGF) receptor and p38 were activated (Zhuang
et al. 2005). In addition, adhesion molecules, such as integrins
(Bokel and Brown 2002, Zuk and Matlin 2002), as well as 
cytokines and chemokines, including tumor necrosis factor
alpha, interleukin 1 beta (IL-1β) (Chung 2001), and trans-
forming growth factor beta (TGF-β) (Humes et al. 1993), may
play important roles in the regulation of the repair process 
of migration–dedifferentiation–redifferentiation. Better 
understanding of all the mediators and mechanisms involved
in dedifferentiation and proliferation of the renal tubule 
epithelial cells will lead to novel approaches to therapies de-
signed to facilitate the recovery of renal histology and func-
tion in humans.
Dedifferentiation in epithelial cells. In ocular tissue,
corneal stem cells and differentiated epithelial cells are located
in different sites, with stem cells in the limbus forming a
ring of tissue around the central cornea, and epithelial cells
in the central area. The stem cells proliferate, migrate cen-
tripetally, and differentiate into the terminal corneal epithe-
lial cells that replace the cells shed in the central cornea.
When Pearton and colleagues (2004, 2005) performed the re-
combination between wild-type mouse embryonic dermis and
adult rabbit central corneal epithelium, they found that the
differentiated cells of the corneal epithelium dedifferenti-
ated and reverted to a limbal basal cell phenotype. This
process was confirmed to be triggered by dermal develop-
mental signals, such as Wnt/β-catenin and BMP (bone
morphogenetic protein)/Noggin signaling.
In our laboratory, we have done a significant amount of
work in dedifferentiation and regeneration. This work includes
a relatively complete system for the isolation, culture, and iden-
tification of certain stem cells.We have also induced these stem
cells to differentiate into many cell types, both in vitro and in
vivo, and explored the possibility of enhancing the healing and
regeneration of skin injury by autotransplantation (Fang et
al. 2004, Fu et al. 2004). We have obtained evidence of the de-
differentiation of epithelial cells to stem cells or stem cell–like
cells in vivo (Fu et al. 2001a, 2001b). It is possible that re-
combinant human epidermal growth factor serves as a de-
differentiation signal, inducing cell reversion to form stem
cell–like islands.We obtained further evidence to demonstrate
this dedifferentiation phenomenon. Human split-thickness
epidermal sheets devoid of basal cells were transplanted onto
full-thickness skin wounds in immunodeficient BALB/c nude
mice. Immunohistochemical examination of the skin grafts
showed that a significant number of cells were positive for stem
cell markers in the suprabasal layer after transplantation.
The results collectively indicated that some of the differenti-
ating cells in grafted epidermal sheets might have dediffer-
entiated into stem cells or stem cell–like cells, and the result
offered us new evidence of and insights into the de-
differentiation of human epidermal cells.
Dedifferentiation in germ cells. Although induction of
dedifferentiation could be useful in tissue regeneration, it
might lead to some pathological processes. Under certain
situations, then, blockage of dedifferentiation might be ben-
eficial in preventing pathological events.
Mature Sertoli cells are the primary supportive cells of
seminiferous epithelium and play an important role in 
regulating the spermatogenic process (de Kretser et al. 1998).
Sertoli cells with immature characteristics have been found
in the adult human testes in some pathological conditions 
associated with impaired spermatogenesis (Steger et al. 1996,
1999, Maymon et al. 2002). Cytokeratin-18 (CK-18) is ex-
pressed only in immature Sertoli cells and is normally lost at 
puberty (Stosiek et al. 1990). Zhang and colleagues (2004)
demonstrated in the rhesus monkey that cryptorchid testis
could induce expression of CK-18 in Sertoli cells coinciden-
tally with a cessation of spermatogenic activity, which indi-
cated that body temperature was capable of inducing adult
Sertoli cells to revert to a dedifferentiated immature state
and of destroying their supportive role in normal spermato-
genesis. To confirm this finding, they did further studies and
found that local testicular heat treatment of an adult mon-
key at 43 degrees Celsius (°C) was capable of activating re-
expression of CK-18 in Sertoli cells. The heat treatment of the
primary Sertoli cell culture isolated from the adult monkey
testis at 43°C could also induce CK-18 reexpression. These 
results from in vivo and in vitro experiments demonstrated
that heat treatment of adult monkey Sertoli cells was capa-
ble of inducing a reversible change in the Sertoli cells from an
adult differentiated state to an immature dedifferentiated
state (Zhang et al. 2006).
Signaling pathways involved in dedifferentiation
Although the signaling pathways involved in dedifferentiation
have not been completely identified, increasing evidence has
shown that the following signaling pathways may play some
critical role in these important phenomena (figure 1).
MAPK signaling pathway. Mitogen-activated protein kinases
(MAPKs) are serine/threonine kinases that transmit signals
from extracellular stimuli to multiple substrates involved in
cell growth, differentiation, and apoptosis. Three major 
subfamilies of MAPKs have been identified: ERK, c-Jun 
N-terminal kinase (JNK), and p38. Most likely, ERK is highly
responsive to mitogen stimulation (e.g., by growth factors),
while JNK and p38 are activated by a variety of genotoxic
stresses, including cell cycle arrest, DNA repair, and apopto-
sis (Roux and Blenis 2004). Renal tubular cell dedifferentia-
tion, namely, epithelial–mesenchymal transition (EMT), is
thought to be a prerequisite for regenerative proliferation
and migration after renal injury. The signaling mechanism of
EMT induced by TGF-β and the EGF receptor involves p38,
and inhibition of p38 activity can prevent EMT. In addition,
ERK activity in differentiated chondrocytes is dramatically in-
creased during the course of dedifferentiation. The process is
blocked after the activation of ERK has been inhibited (Yoon
et al. 2002). Likewise, ERK signaling pathway activation 
correlates with dedifferentiation of smooth muscle cells.
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Pretreatment of smooth muscle cells with ERK inhibitor
suppresses the ERK cascade, abolishes the down-regulation
of desmin, and leads to cell cycle arrest (Vogel et al. 2006). The
JNK-mediated c-Jun phosphorylation pathway is also 
required for IL-1β-induced dedifferentiation of articular
chondrocytes (Hwang et al. 2005).
Wnt/β-catenin signaling pathway. Beta-catenin, a compo-
nent of the cadherin cell adhesion complex, plays an impor-
tant role in E-cadherin-mediated cell–cell adhesion and is an
important intermediate in the Wnt signaling pathway. It has
been conclusively demonstrated to regulate dedifferentia-
tion. In the absence of Wnt signaling, β-catenin is phospho-
rylated by functional interaction with glycogen synthase
kinase 3 beta (GSK-3β) and subsequently targeted to degra-
dation by the ubiquitin-proteasome system (Polakis 1997).
Activation of the Wnt pathway inhibits GSK-3β activity and
thus induces stabilization of β-catenin, causing transloca-
tion of β-catenin to the nuclei, where its association with 
T-cell factor/lymphocyte enhancer factor (Tcf/Lef) causes
transcriptional activation of target genes (Clevers and van de
Wetering 1997). Accumulation of β-catenin and subsequent
stimulation of Tcf/Lef transcriptional activity causes dedif-
ferentiation of articular chondrocytes (Hwang et al. 2005). In
a primary culture of articular chondrocytes, IL-1β induces ex-
pression of β-catenin and Wnt-7α, and Wnt-7α induces
dedifferentiation of articular chondrocytes by stimulating
the transcriptional activity of β-catenin (Hwang et al. 2004).
In addition, β-catenin plays a direct role in the dedifferenti-
ation observed in thyroid cancer and is the key signaling in-
termediate involved in the EMT (Zhuang et al. 2005).
Other signaling pathways. Brawley and Matunis (2004) found
that in the Drosophila male germ line, local activation of the
Janus kinase–signal transducer and activator of transcription
(Jak-STAT) pathway maintained stem cells,
whereas germ-line stem cells lacking Jak-
STAT signaling differentiated into sper-
matogonia without self-renewal. So through
conditional manipulation of Jak-STAT sig-
naling, spermatogonia that are undergoing
limited mitotic (transit-amplifying) divi-
sions can repopulate the niche and revert to
stem cell identity. Other signaling pathways
involved in dedifferentiation include Notch
signaling reactivation in dedifferentiated
pancreatic cells (Jensen et al. 2005), BMP/
Noggin signaling (Pearton et al. 2005), and
other unidentified signaling in the stem 
cell niche (Moore and Lemischka 2006).
Although several signal mechanisms have
been found to play important roles in de-
differentiation and regeneration, they are
members of a regulatory network with mul-
tiple feedback loops. We believe that de-
differentiation and regeneration are more
complicated than previously thought, and that numerous
inducing factors and signal pathways coordinate mutually to
promote these processes.
Conclusions
It has long been thought that once mammalian cells are 
committed to a specific lineage, they can no longer change their
fate, and thus they become so-called terminally differentiated
cells. But recent studies suggest that differentiated mam-
malian cells can be induced to assume new fates under 
appropriate conditions, a phenomenon termed dedifferenti-
ation. By better understanding the biology of stem cells, re-
searchers may be able to manipulate pluripotent stem cells to
produce a great variety of cell types. Even more exciting is the
prospect that the induction of dedifferentiation may make it
possible to produce pluripotent stem cells from an individ-
ual’s terminally differentiated cells, including cells that can be
harvested using noninvasive procedures. These cells could then
be expanded and transplanted back into the injured organ in
the hope of inducing a regenerative response.
Much work needs to be done, however, before cellular
dedifferentiation can be used for therapeutic purposes. First,
it seems that different cell types undergo different dediffer-
entiation processes, and so far, regardless of the cell line, a 
stable and efficient dedifferentiation-inducing model has not
been developed. If such a model system can be established,
the study of dedifferentiation will become easier and its 
manipulation more efficient. Although we have established
a human sheet transplantation model in immunodeficient
BALB/c nude mice, which could be used to observe the 
dedifferentiation of human epidermal cells and to collect
dedifferentiated cells, its stability and effectiveness still need
to be evaluated.
Second, an important direction for future research in
chemical biology is the derivation of compounds that could
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Figure 1. Candidate extrinsic signaling pathways that regulate dedifferentiation.
affect cellular differentiation or its reversal (Kim et al. 2004).
The discovery of reversine seems to be a breakthrough in that
a small-molecule treatment might possibly transform one cell
type into another. However, though reversing the differenti-
ation of C2C12 cells is a fascinating development, reversing
the differentiation of a cell obtained directly from muscle tis-
sue of a human poses a much greater challenge. Besides,
there are other questions to be answered in regard to rever-
sine: Is it effective only on myoblasts, or can it act on other
cell types? Can reversine change adipocytes or bone cells
into muscle cells? All in all, the search for small-molecule de-
differentiation of other cell types will probably keep scientists
in this field busy for many years to come.
Third, scientists have always been puzzled about the mech-
anism of dedifferentiation. Although recent published papers
suggest that under certain circumstances, some induction
signals might be sufficient to induce dedifferentiation of dif-
ferent cell types, many questions have not been adequately 
answered. The genes that control cellular dedifferentiation have
not yet been completely identified, and the genes that have
been shown to induce cellular dedifferentiation in cultured
cells need to be further tested in animals to determine whether
they function similarly in vivo. In addition, it is not clear
what the fate of dedifferentiated cells would be. Would they
respond to endogenous cues in the host tissue and rediffer-
entiate into the appropriate cell types, or would differentia-
tion signals also need to be supplied externally? Tight control
of the dedifferentiation gene’s expression will be required so
that it can be incited to initiate the dedifferentiation process
and subsequently terminated so that redifferentiation can
take place. Therefore, if researchers identify which genes or
signaling pathways act as the key factors during this process,
we can potentially control the whole dedifferentiation process
at will; the process of dedifferentiation can easily be turned
on and off by activating or closing the expression of certain
genes. When it comes to regeneration, however, the situation
may not be so simple: To induce endogenous regeneration,
it may be necessary that all the genes controlling dedifferen-
tiation, redifferentiation, and patterning be expressed at the
appropriate levels in the correct temporal and spatial context
(Odelberg 2002). If so, a complete understanding of the
molecular mechanisms that control the regenerative process
will be neccessary.
Finally, the purpose of basic medical research is mainly to
apply research results in the clinical setting. The study of
dedifferentiation is not an exception. Until now, it has not been
clear whether these dedifferentiation-derived progenitor cells,
or stem cell–like cells, could perform the same functions as
embryonic or adult stem cells isolated from the body. Do the
induced stem cells contain the same potentiality as native stem
cells, and can they differentiate into a wide variety of cell types? 
Dedifferentiation is likely to become a new focus in stem
cell research because of its importance in fields such as 
stem cell biology, regenerative medicine, cancer research,
and aging. We hope the foregoing and future studies in de-
differentiation will bring us closer to achieving the ultimate
goal of enhancing endogenous regenerative processes in
mammals. But there is still a long way to go before these
hopes are realized.
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